Peritoneal fluid cytology in endometrial cancer: Its significance and the role of chromic phosphate (32P) therapy
- 1 October 1988
- journal article
- research article
- Published by Elsevier in International Journal of Radiation Oncology*Biology*Physics
- Vol. 15 (4) , 815-822
- https://doi.org/10.1016/0360-3016(88)90112-5
Abstract
No abstract availableThis publication has 16 references indexed in Scilit:
- The influence of positive peritoneal cytology in clinical stage I endometrial adenocarcinoma and approaches to it's treatmentInternational Journal of Radiation Oncology*Biology*Physics, 1986
- Intraperitoneal chromic phosphate P 32 suspension therapy of malignant peritoneal cytology in endometrial carcinomaAmerican Journal of Obstetrics and Gynecology, 1985
- Treatment planning for colorectal cancer: radiation and surgical techniques and value of small-bowel filmsInternational Journal of Radiation Oncology*Biology*Physics, 1985
- Prognostic significance of peritoneal cytology in patients with endometrial cancer and preliminary data concerning therapy with intraperitoneal radiopharmaceuticalsAmerican Journal of Obstetrics and Gynecology, 1981
- Radioactive chromic phosphate suspension: Studies on distribution, dose absorption, and effective therapeutic radiation in phantoms, dogs, and patientsGynecologic Oncology, 1981
- Experience with peritoneal cytology in the management of gynecologic malignanciesAmerican Journal of Obstetrics and Gynecology, 1974
- The prognostic value of peritoneal cytology in gynecologic malignant diseaseAmerican Journal of Obstetrics and Gynecology, 1971
- Malignant Tumors of the Ovary Managed with Postoperative Megavoltage IrradiationRadiology, 1969
- Radioactive colloidal chromic phosphate in the treatment of ovarian malignanciesAmerican Journal of Obstetrics and Gynecology, 1969
- Nonparametric Estimation from Incomplete ObservationsJournal of the American Statistical Association, 1958